Musculoskeletal Pain
📧 Sign up to get email alerts when something new happens for Musculoskeletal Pain.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-09-28FDA Approved: METHOCARBAMOL — Supplemental Application (Solco Healthcare LLC)
FDA approved a supplemental application for methocarbamol from Solco Healthcare LLC.
-
CLINICAL_TRIALS trial_result · 2012-06-19Clinical Trial Update: Evaluating a Chronic Pain Treatment Program [Phase 1]
This update confirms the completion of a Phase 1 clinical trial evaluating a chronic pain treatment program for chronic musculoskeletal pain…
-
FDA approval · 2011-11-16FDA Approved: CARISOPRODOL — Supplemental Application (Ingenus Pharmaceuticals, LLC)
The FDA approved a supplemental application to authorize a generic Carisoprodol product from Ingenus Pharmaceuticals, LLC.
-
FDA approval · 2011-08-30FDA Approved: ORPHENADRINE CITRATE — Original Application (Sagent Pharmaceuticals)
FDA approved Orphenadrine citrate under an Original Application for Sagent Pharmaceuticals.
-
CLINICAL_TRIALS trial_result · 2011-07-06Clinical Trial Update: Mentholated Cream Containing Oxygenated Glycerol Triesters on Acute Pain of the Muscles and Joints [Phase 1, Phase 2]
Phase 1 and Phase 2 trials evaluated a mentholated cream containing oxygenated glycerol triesters for acute musculoskeletal pain and have co…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2011-06-06FDA Approved: SALONPAS PAIN RELIEF — Supplemental Application (Hisamitsu Pharmaceutical Co., Inc.)
FDA approved a supplemental application for SALONPAS PAIN RELIEF (menthol, methyl salicylate) from Hisamitsu Pharmaceutical Co., Inc.
-
FDA approval · 2011-04-12FDA Approved: CYMBALTA — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Cymbalta (duloxetine hydrochloride) submitted by Eli Lilly and Company.
-
CLINICAL_TRIALS trial_result · 2011-03-24Clinical Trial Update: Modulation of Central Hypersensitivity in Chronic Musculoskeletal Pain by Intravenous Tropisetron [Phase 2]
A Phase 2 clinical trial investigating intravenous tropisetron for modulation of central hypersensitivity in chronic musculoskeletal pain ha…
-
FDA label_change · 2010-09-13FDA Approved: SALONPAS PAIN RELIEF — Supplemental Application (Hisamitsu Pharmaceutical Co., Inc.)
FDA approved a supplemental application for SALONPAS PAIN RELIEF to modify labeling (menthol, methyl salicylate) by Hisamitsu Pharmaceutical…
-
EMA safety_alert · 2010-07-22European Medicines Agency confirms positive benefit-risk balance of topical formulations of ketoprofen
The EMA confirms a positive benefit-risk balance for topical ketoprofen formulations, underscoring their continued use for pain relief with …
-
CLINICAL_TRIALS trial_result · 2010-06-28Clinical Trial Update: Study of Epicutaneously Applied Ketoprofen Transfersome® Gel With or Without Combination With Oral Celecoxib for the Treatment of Muscle Pain Induced by Eccentric Exercise [Phase 1]
Phase 1 study evaluating epicutaneously applied ketoprofen transfersome gel, with or without oral celecoxib, for muscle pain induced by ecce…
-
FDA approval · 2010-03-30FDA Approved: ORPHENADRINE CITRATE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for orphenadrine citrate submitted by Sandoz Inc.
-
FDA approval · 2010-03-10FDA Approved: CARISOPRODOL — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for Carisoprodol from Rising Pharma Holdings, Inc. The approval updates the regulatory status of thi…
-
FDA approval · 2009-11-17FDA Approved: SOMA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Soma (carisoprodol) submitted by Viatris Specialty LLC.
-
FDA approval · 2009-11-06FDA Approved: SOMA — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Soma (carisoprodol) submitted by Viatris Specialty LLC.
-
FDA approval · 2009-11-06FDA Approved: METHOCARBAMOL — Original Application (XLCare Pharmaceuticals Inc.)
FDA approved methocarbamol as a generic product via an Original Application submitted by XLCare Pharmaceuticals Inc. The approval provides a…
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Efficacy and Safety of Salonsip Compared to Sabiá Plaster [Phase 3]
A Phase 3 trial compares Salonsip with Sabiá Plaster to assess efficacy and safety; current status is unknown.
-
FDA approval · 2009-09-03FDA Approved: FLECTOR — Supplemental Application (IBSA Pharma Inc.)
FDA approved a supplemental application for FLECTOR (diclofenac epolamine) from IBSA Pharma Inc. The action pertains to modifications to the…
-
CLINICAL_TRIALS trial_result · 2009-05-20Clinical Trial Update: Musculoskeletal and Obstetric Management Study [NA]
Clinical trial update for the Musculoskeletal and Obstetric Management Study sponsored by Logan College of Chiropractic; investigating lower…
-
FDA approval · 2009-01-29FDA Approved: CARISOPRODOL — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for carisoprodol submitted by Chartwell RX, LLC.
-
FDA approval · 2009-01-06FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Supplemental Application (Solco Healthcare U.S., LLC)
FDA approved the supplemental application for cyclobenzaprine hydrochloride (Solco Healthcare U.S., LLC).
-
FDA approval · 2008-10-22FDA Approved: CARISOPRODOL — Original Application (Ingenus Pharmaceuticals, LLC)
The FDA approved the original application for carisoprodol from Ingenus Pharmaceuticals, authorizing a generic version of this muscle relaxa…
-
FDA approval · 2008-09-26FDA Approved: CYCLOBENZAPRINE HYDROCHLORIDE — Original Application (Rising Pharma Holdings, Inc.)
FDA approved cyclobenzaprine hydrochloride from Rising Pharma Holdings, Inc. under an Original Application (ANDA) for relief of muscle spasm…
-
FDA approval · 2008-08-25FDA Approved: SALONPAS PAIN RELIEF — Supplemental Application (Hisamitsu Pharmaceutical Co., Inc.)
FDA approved a supplemental application for SALONPAS PAIN RELIEF (menthol, methyl salicylate) from Hisamitsu Pharmaceutical Co., Inc.
-
FDA approval · 2008-08-22FDA Approved: GOOD SENSE CHILDRENS IBUPROFEN — Supplemental Application (L. Perrigo Company)
FDA approved a supplemental application for Good Sense Children’s Ibuprofen (ibuprofen) from L. Perrigo Company.